John M. Humphrey

机构：Pfizer (United States), Indiana University School of Medicine, Indiana University – Purdue University Indianapolis · ORCID：0000-0001-8753-9479

发表论文 64 篇 · 总被引 3511 次 · h-index 28

代表论文

• Design and Selection Parameters to Accelerate the Discovery of Novel Central Nervous System Positron Emission Tomography (PET) Ligands and Their Application in the Development of a Novel Phosphodiesterase 2A PET Ligand (2013 · Journal of Medicinal Chemistry · 被引 207)
• Enantioselective Total Syntheses of Manzamine A and Related Alkaloids (2002 · Journal of the American Chemical Society · 被引 207)
• Introduction of a Crystalline, Shelf-Stable Reagent for the Synthesis of Sulfur(VI) Fluorides (2018 · Organic Letters · 被引 143)
• Sulfonamide Synthesis via Calcium Triflimide Activation of Sulfonyl Fluorides (2018 · Organic Letters · 被引 127)
• Phosphodiesterase 10A inhibitors: a novel approach to the treatment of the symptoms of schizophrenia. (2007 · PubMed · 被引 114)
• Discovery of a Series of 6,7-Dimethoxy-4-pyrrolidylquinazoline PDE10A Inhibitors (2006 · Journal of Medicinal Chemistry · 被引 114)